Loading chart…
PRE-MARKET
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases.
Mankind Pharma Limited (MANKIND) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The MANKIND share price is ₹2,668.30 (+5.05% today), with a market capitalisation of ₹1.10T and a price-to-earnings (P/E) ratio of 50.0. MarketRipple tracks the MANKIND investment thesis, the ripple-chain impact of market events on Mankind Pharma Limited, and the Healthcare sector outlook.
Open
₹2,600.00
High
₹2,705.00
Low
₹2,585.20
Prev. Close
₹2,540.00
52W High
₹2,705.00
52W Low
₹1,909.70
Day range
₹2,585.20–₹2,705.00
52-week range
₹1,909.70–₹2,705.00
Volume
1.5M
P/E
50.0
ROE
13.6%
D/E
0.39
Margin
14.6%
Mankind Pharma Limited (NSE: MANKIND) is currently trading at ₹2,668.30 (+5.05%).
Mankind Pharma Limited's market capitalization is ₹1.10T.
Mankind Pharma Limited's price-to-earnings (P/E) ratio is 50.0.
Mankind Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Mankind Pharma Limited currently reads positive, based on 19 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.